What is the Bluejay Diagnostics Inc. stock price forecast?

Bluejay Diagnostics Inc. is currently trading at $1.15. View real-time AI analysis on Alpha Lenz.

What is Bluejay Diagnostics Inc. insider trading activity?

View the latest insider trading data for Bluejay Diagnostics Inc. on Alpha Lenz.

What is Bluejay Diagnostics Inc.'s P/E ratio?

Bluejay Diagnostics Inc.'s P/E ratio is -0.1.

Bluejay Diagnostics Inc.

NASDAQ · BJDX

$1.15+0.00(+0.00%)Pre-market

Ask about Bluejay Diagnostics Inc.'s future dividend policy...

Alpha Chat Insight

“Bluejay Diagnostics Inc. trades at a P/E of -0.1 (undervalued) with modest ROE of -117.0%.”

Ask for details →

Company Overview

Bluejay Diagnostics Inc. is a biotechnology company specializing in developing compact, point-of-care diagnostic systems. Its primary function is to create innovative solutions that enable rapid and accurate testing, particularly in decentralized healthcare settings like doctor's offices or clinics. The company focuses on leveraging advanced technology to deliver cost-effective and efficient diagnostic results, allowing healthcare providers to make informed clinical decisions quickly. Bluejay Diagnostics is significant in the biotechnology and healthcare sectors as it aims to improve patient outcomes through its state-of-the-art detection systems, thereby enhancing diagnostic capabilities. The company operates in a growing market segment that emphasizes accessible and immediate healthcare solutions, reflecting a shift towards personalized and real-time patient care.

CEOMr. Indranil Dey

Websitehttps://bluejaydx.com

SectorHealthcare

IndustryMedical Devices

Employees5

Company Statistics

FY 2025

Profile

$516.40KMarket Cap

$0.00Revenue

0.00Shares Out

5Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

-0.08P/E

0.09P/B

N/AEV/Sales

0.68EV/EBITDA

-0.08P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-99.42%ROA

-117.02%ROE

-99.41%ROIC

Financial Health

$5.16MCash & Cash Equivalents

$-4.02MNet Debt

19.14%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Bluejay Diagnostics Inc. trades at a P/E of -0.1 (undervalued) with modest ROE of -117.0%.”

Ask for details →

Frequently Asked Questions

Bluejay Diagnostics Inc. (ticker: BJDX) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 5 employees. Market cap is $516,399.

The current price is $1.15 with a P/E ratio of -0.08x and P/B of 0.09x.

ROE is -117.02%.